MDT

Secret_Tapeworm

https://preview.redd.it/p098nr7zpyjh1.jpeg?width=1179&format=pjpg&auto=webp&s=82d769fc2af70e2bbe03e378dc26f29a0960d013 Good luck OP! (pic is the 4-hour chart, MDT time zone)

Midpoint60

I was flat today (again) as well. It seems that healthcare is making up for my loses in tech -- LLY, ABBV, PFE, BMY, ABT, and MDT are my healthcare holding.

AdministrativeDisk83

almost but in reverse. South Korea is 13 hours ahead EDT, 12 hours ahead CDT, 11 hours ahead for MDT, and 10 hours ahead for WDT. Its an extra hour added during standard time. We are currently in daylight savings time. That being said, they are ahead of us. It is almost noon on Wednesday, July 15th there right now.

PulIthEld

ISRG — Quick DD $402 · ~51x P/E · $142B cap · near 52-wk low Business: Robotic surgery leader (da Vinci). ~60% recurring "razor-blade" revenue, wide moat (installed base + surgeon switching costs). Good: Revenue $4.4B→$10B since 2020, growth accelerating to +21% (2025); 18% procedure growth; best-in-class margins, net cash. Bad: Down 33% from highs on (1) valuation reset from ~70x, (2) growth decel (2026 guide +13-15%), (3) real competition arriving (Medtronic Hugo, J&J Ottava). Still priciest in its peer group (vs SYK 36x, MDT 22x). Verdict: Quality compounder, fairer-but-not-cheap. Business is intact (the premium came out, not the fundamentals). Competitors have the hardware but haven't breached the moat. Accumulate on weakness if you believe the moat holds — not a screaming bargain. Watch Hugo/Ottava share trends.

Lacklusterlandon

I just stuck to a few inverse ETFs for leveraged exposure but cheaper premiums that the direct index so spxs, soxs, sqqq. I’ve used finviz scanner to find some rvol stuff with gaps but cheap stocks with affordable premiums are limited. Have been in a few like BB, Nok, keel, MDT but mostly sticking to the aforementioned

Scary-Bobcat-9444

This article also mentions Neuralink's competitors. If you don't like the companies Elon Musk invests in, you can support its competitors NPCE/NMTC/MDT/INSP or ARK Invest's Genomic Revolution ETF (ARKG).

Intelligent-Bell7452

oh, also different time zones haha im MDT so. 8 MDT!

Tall-Illustrator543

If anyone wants a decent defensive, check out MDT. Good financials, good tax structure and decent outlook

RealPennyMuncher

CBRE🟢 WFC 🟢 RSG🟢 ABT 🟢 CTAS🟢 IR🟢 MDT🟢 SSNC🟢. Munch munch munch 🦧🍿

ricknad

MDT cause it's cheap xD

ricknad

thoughts on MDT?

PomegranateLow4300

MDT mate 

pegasusCK

Bro if youre hands are truly tied by morality then just literally google that shit for ideas for ethical companies to invest in there are plenty: * **Renewable Energy:** **NextEra Energy (NEE)** is a major investor in wind and solar infrastructure. * **Environmental Sustainability:** **Waste Management (WM)** focuses on recycling, waste reduction, and renewable landfill gas. * **Healthcare:** **Thermo Fisher Scientific (TMO)** and **Medtronic (MDT)** lead in life sciences and ethical medical technology innovation. * **Consumer Goods:** **PepsiCo (PEP)** and **Costco (COST)** are recognized for supply chain sustainability and strong employee satisfaction metrics.

Marketspike

Totally agree that MODD is a risky stock...but there is no way someone could buy MDT and have a possibility for a 100% gain in the next six months. It is a possibility with MODD. jmo ANY is interesting because it seems half the market knows that the merger is coming and the other is not putting the public info together.

RealPennyMuncher

Watching to add a 2nd batch of MDT

RealPennyMuncher

MDT reversal?

RealPennyMuncher

Watching WCN, MDT, WCN

dvdmovie1

The issue I have across the board is that medtech is as out of favor as software. You mention Resmed, but look at the YTD for ABT, MDT, SYK, ISRG, BSX, etc. Given that, if earnings aren't great then people are selling. Cheap has to be cheaper than before in this market if something doesn't have an appealing narrative around it and/or has some degree of various headwinds. Graph showing healthcare as a % of the S&P tanking to lows of the late 1990's: https://pbs.twimg.com/media/HHzT3jyXMAYFg43?format=jpg&name=medium

ryanl247

I like MDT, personally

curious_skeptic

Diabetes care, healthcare technology. This sector is rather beat down lately, but the multiples are solid and should weather a down-turn nicely, plus good growth potential. ABT, DXCM, MDT, GEHC, NVO. Maybe BAX or possibly even PODD.

ryanl247

If you think semis will continue to do well, soxx or smh are probably the safest bets. I do think semis will do well in future but they've also run up a lot very quickly. ETFs will have less downside risk than individual names, so if you have to buy something at the highs, make it an ETF and potentially save yourself some pain. The general rule is also don't overexpose; buy a broad ETF like vt or vtsax, but if it's not a ton of money in the grand scheme of things and you're after portfolio growth, narrowing selectively is understandable, as long as you can stomach volatility and don't do go too narrow. I've been doing this for quite a while so I would not recommend buying individual stocks like I do, unless it's with a small percent of your portfolio, but if you have to, I don't think you can go wrong with Google, though if there is a pullback Google will drop as well but not as much as other stocks imo. I took a lot of risk off yesterday by selling my calls but buying shares of equal dollar value in the ones that haven't run as much or I believe still have tremendous upside, whether or not that is right now or down the line. I normally buy a lot of things when they're down big and starting to show signs of recovery or are very oversold. I've done quite well since the low, so I'm starting to diversify a little using profits. I started scaling into MDT. I am taking VERY tiny nibbles of PLTR. Some fintech. Etc. I'm also hedging as I think sometime from now to the end of next week could be bumpy, but I also don't want to miss a large move up or a sector rotation. I watch the market closely and Ill probably go aggressively short at some point within the next few weeks, but it depends on the price action. Anyway, I don't want to scare you. You SHOULD be investing, but unless you can stomache a lot of downside, don't go with individual names and/or break apart your buys to average in over time.

ateranol

I'm knee deep in SaaS calls, looking into getting into medical devices (BSX, MDT) too, as they've crashed to pre-covid lows. These plays never work out for me, but I still try.

NaluknengBalong_0918

!p vm analyze the option chain of MDT for me

NaluknengBalong_0918

VM analyze the option chain of MDT for me

UndercoverOptions

Blue chip dividend paying stocks that are trading below their FMV. PEP, T, NVDA, MET, CTSH, GIS, MDT, MU, IBIT are just some of the my current positions. No risk, no hype. Solid companies with strikes below FMV.

NaluknengBalong_0918

VM analyze the option chain of MDT for me

f1ve-Star

For me I usually have a "get out price" calculated when I buy. Once it reaches that price (give or take) I sell and find another stock I like better. There are always under valued companies. (MDT, AOS, SWK all look good to me right now) Where I have trouble is when the stock doesn't go up like I expect I will hold the damn thing forever. Especially if it's red. Lost opportunity is a thing.

salty0waldo

I have been looking at medical device companies since the end of last year, never ended up adding any but BSX and MDT were both on my radar. I guess those are the two leaders so not really gems lol. The price action didn't make a ton of sense on the downgrade but the recent acquisition was fairly large if I recall?

5365616E48

Do you own DD, buy since you asked. These have been the most stable for me. WMT - Walmart MDT - Medtronic SCHD - Schwab US Dividend Equity ETF

Stocks_N_Bondage

Opened today for stocks announcing Tuesday 17th before market open: - Calls: WAY • MDT • CNH - Puts: CEVA • GPC Note: I also had puts on ITRI but sold just be market close today. Disclaimer: Not recommendations nor investing ad vice.

Glam34

MDT isnt bad

Stocks_N_Bondage

Calls: ASST • WAY • MDT • CNH Puts: ITRI • CEVA • NEO • GPC

Stocks_N_Bondage

Opened today: Announcing after market: - Calls: ASST Announcing Tuesday before market open: - Calls: WAY • MDT • CNH - Puts: ITRI • CEVA • GPC

KuroFafnar

QCOM, 222 @ $158 WY, 350 @ $31 MDT, 180 @ $90 MKSI, 165 @ $109 UPS, 135 @ $112 Gotta harvest at some point, didn't feel those would outperform even VXUS this year. I was wrong about MKSI but correct on the others.

theopcrackhead

Medtronic, let me tell you why. Short interest is elevated, earnings are trending up, a spin-off is on deck, and innovation/regulatory catalysts are hitting. With analysts raising targets and activist oversight, MDT looks positioned for upside.

_hiddenscout

$MDT | Medtronic Q226 Earnings:  - Adj EPS: $1.36 (est 1.32)  - Revenue: $8.96B (est $8.87B)  - Adj Oper Margin: 24.1% (est 24.3%)  - Sees FY Organic Revenue About +5.5% (saw +5%)  - Sees FY Adj EPS Between $5.62 - $5.66 (saw $5.60 - $5.66)

StocksStormTrooper

Feeling good about MDT earnings gs

Stocks_N_Bondage

Today: - Calls: BIDU MDT TCOM NMM PDD ENR - Puts: HD BRBR Really not sure about BIDU, but we'll see.

yatruthordare

MDT AND XOM are my only greens today - all else scary red -I guess I’ll sit on my hands tomorrow - or try to get the courage to buy the dip….

friend-buddy

MDT is spinning off their diabetes unit into a separate entity. I'm guessing they'll see how MODD does with the Pivot pump launch and then will swoop in.

United_Recover7190

Medtronic (MDT) just walked away from an acquisition in this space due to patent issues. They are probably taking to MODD already.

SideEast2368

Cath lab tech here: penumbra is great, and all these medical device companies are filthy rich (see Stryker, ABT, MDT) and I am starting to stash my money in this sector, but this specific device, if not rendered useless, won’t be adopted until we have AI CV surgeons. Clots are bombed with meds and easily verified with fleuro in real time. No special caths needed. Penumbra is mostly known in the sector for their coils which plug aneurysms and such. X-ray tech is the only thing I see getting any AI integration in the lab, which is currently being tested in field. I think the one we have is made by abbot specifically, and is used in place of an ICE catheter which is basically an IV ultrasound. The quality is better, but that’s ab it. That being said, PEN along with all the other stocks I mentioned will be about as safe a position as Walmart, NVDA, etc. That is, if this vicious insurance premium spike doesn’t completely fuck hospital systems worldwide.

5365616E48

(Sorted by positions sizes) ASTS - Like the technology RGTI - Momentum stock RKLB - Momentum stock MDT - Stability / Dividends SMCI - Running the wheel strategy SWBI - Stability / Dividends AVAV - Growth

Patient_Ad_6209

https://preview.redd.it/518r3a8gniuf1.jpeg?width=1284&format=pjpg&auto=webp&s=707e60ea3a438d476ac08a45e3e518065a3e7d82 Had to check if it was me but appearantly I got mine for $0.81 an hour later (MDT) lol

Educational_Pie_9572

See you know the pressure man. I did almost the same thing yesterday. Seen some in the money premiums that weren't too expensive. Bought 5 contracts of $RGTI and within 18 minutes. They were profit of $1000 already and I went to go text my buddy to get in as quick as possible, and I came back to them being at $600 and eventually down to $300 and then $100 of profit at 2 hours into the market at 9:30am MDT. I told myself that I know there's usually another bump at 11:30AM. So I'm going to wait 2 brutal hours and see if I can squeeze out some more money than just a $100 in profit. When it was at $1000 and i blinked for 30 seconds and it all crashed down. Lol. By waiting those 2 extra hours. Which is my problem with time discipline I created this post about. I was able to turn a $100 profit into $580 profit after missing out on the $1000. But that $1000 would have been really nice to have for 20 minutes of work. $580 is good for 4 hours. With the missing out on that money yesterday and the money I missed out on this morning. That's why I made this post about needing to have more time discipline.

Educational_Pie_9572

I asked my PhD AI Girlfriend Assistant that i have a stock market project dedicated to in CGPT that i use to help me learn. This is what she had to say. [Oct 1 2025 4:21 PM MDT] This poor guy walked himself right into the dark side of selling puts. Let’s break it down cleanly so it makes sense, because he’s asking the exact right “uh oh” questions after selling OTM puts on $OPI (Office Properties Income Trust), which is circling the drain. 1. Will I get stuck with delisted shares if they are exercised? Yes. If the company is delisted and someone exercises those puts, you’ll be assigned the stock at your strike price. You will own the shares whether they trade on Nasdaq, OTC (over-the-counter), or even eventually head to zero. If it goes fully bankrupt, your shares are basically wallpaper. The exchange doesn’t protect you from being assigned just because the stock is delisting. 2. Can it go OTC before my options expire, and if so, what happens to the options? Yes, companies that fail Nasdaq listing requirements often move to the OTC (pink sheets). When that happens: The options usually stop trading once the stock is delisted, but they don’t disappear immediately. OCC (Options Clearing Corporation) will either adjust them or settle them based on the OTC shares. If the stock still exists OTC, the options remain tied to those shares, just way less liquid. If the company goes bankrupt and cancels the equity, the options can be settled for $0 intrinsic value if OTM, or cash/stock if ITM (but typically worthless for the put seller, since you’ll be forced to buy at the strike). 3. What happens to the premium I collected if they don’t exercise? You keep it. Premium collected is yours the moment you sell the put. If the buyer doesn’t exercise and the option expires, the premium is pure profit. The catch is, if $OPI keeps tanking, those puts are deep ITM, and exercise is almost guaranteed because the buyer wants to dump their stock at a higher strike. --- Bottom line for him: He’s on the hook. Selling puts is a promise to buy shares, and if $OPI collapses, he’ll be assigned worthless or nearly worthless shares. If $OPI trades OTC, the obligation follows it—he still has to take those OTC shares. If bankruptcy wipes out the stock completely, the put buyer will exercise (or OCC will auto-exercise ITM), and he’s left buying into nothing. The only way out now is to close those puts by buying them back—probably at a nasty loss—before delisting/bankruptcy finalizes. This is one of those textbook “you collected a few dimes, but the steamroller was faster than you thought” cases. 😬 --- TLDR Summary: He will almost certainly get assigned if $OPI is delisted/bankrupt, meaning he’ll own garbage shares and that fucking sucks for him. Options still function if it goes OTC, but liquidity dies. The premium is already his, but it won’t offset the assignment losses. Only way to avoid the worst is buying back the puts before assignment.

AntoniaFauci

Mornings when I have time I look up the oddball tickers that are up insane amounts, the ones that go from $2 to $12 overnight, or $1 up to $50 as happened this week. In 2025, these have invariably been some kind of coin venture, usually associated with someone from the trump crime family, Today for example there’s one up 10x and sure enough, it’s some incomprehensible crypto thing involving the odious grifter Vivek Ramaswamy. So when I see this Cuprina of Cayman Islands stock, up from 0.70 to $3 I’m expecting to see yet another coin venture pump. But it’s actually some biotech. Skim search indicates they’re working on things like bullfrog collagen skin treatements, leeches for medical wound care, and most unexpected: “Medifly” which they say involves “Maggot Debridement Therapy (MDT)” and uses sanitary blowfly larvae.

0K-go

MO and MDT saving me today.

theadvancedip

Buy MDT and VIK save my calls I need money for tuition

CartographerWarm1859

Guess I'm working overtime XP and MDT calls massacred

CartographerWarm1859

I hope not. Or im going to have to do overtime with monies lost on $XP calls and MDT calls

CartographerWarm1859

Xp calls toasted. Hope my 100 MDT calls can cover my losses

TheHyenaofWallstreet

Need MDT to drop 10% in the morning

MyndexResearch

Added: **MDT 90/95 STRANGLE Sept**... Probably will leg out profit side in the morning and freeroll the other leg.

MyndexResearch

**MDT 90/95 STRANGLE Sept**... Probably will leg out profit side in the morning and freeroll the other leg.

CartographerWarm1859

Xp $18.5 calls weekly and MDT $100 calls print for me. Need that mortgage monies

CartographerWarm1859

MDT 100 calls weekly calls because im a degen trader

fast412

Is anyone making a play on MDT? My wife is type 1 diabetic and used to use Medtronic for her insulin pump and it was complete trash so I might be biased but the put/call ratio seems like most people are going with puts...

CartographerWarm1859

MDT calls?

Kolby833

MDT earnings on Tuesday is going to be very interested, curious to hear what’s going on!

originalpjy

For next week I like puts on TGT, MDT, BDR and ZM.

Veritas_Et_Amor

ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment ProPhase Labs, Inc. Tue, August 12, 2025 at 6:00 AM MDT U.S. Patent No. 12379378-B2 protects biomarker-driven systems and methods to assess progression risk in Barrett’s esophagus and esophageal adenocarcinoma; issuance follows the successful BE-Smart™ test validation (>95% technical success) and, together with BE-Smart’s demonstrated compatibility with both brush and forceps biopsies, supports earlier detection. .35 🪙 💰 🤑 Low float Penny Stock PRPH currently has extremely high volume at 250 million and climbing 👌!! New Patent with 95% efficient Drug Pipeline approved 👍

Veritas_Et_Amor

ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment ProPhase Labs, Inc. Tue, August 12, 2025 at 6:00 AM MDT U.S. Patent No. 12379378-B2 protects biomarker-driven systems and methods to assess progression risk in Barrett’s esophagus and esophageal adenocarcinoma; issuance follows the successful BE-Smart™ test validation (>95% technical success) and, together with BE-Smart’s demonstrated compatibility with both brush and forceps biopsies, supports earlier detection. .35 🪙 💰 🤑 Low float Penny Stock PRPH currently has extremely high volume at 250 million and climbing 👌!! New Patent with 95% efficient Drug Pipeline approved 👍

Veritas_Et_Amor

ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment ProPhase Labs, Inc. Tue, August 12, 2025 at 6:00 AM MDT U.S. Patent No. 12379378-B2 protects biomarker-driven systems and methods to assess progression risk in Barrett’s esophagus and esophageal adenocarcinoma; issuance follows the successful BE-Smart™ test validation (>95% technical success) and, together with BE-Smart’s demonstrated compatibility with both brush and forceps biopsies, supports earlier detection. .35 🪙 💰 🤑 Low float Penny Stock PRPH currently has extremely high volume at 250 million and climbing 👌!! New Patent with 95% efficient Drug Pipeline approved 👍

CEHParrot

NFA IXHL How We’re Looking: According to Grok 1. Risk of a Drop: * The 20–40% chance of a drop remains, given the overbought RSI (95.18) and yesterday’s -35.58% close from $1.63 to $1.05. The retreat from $1.34 to $1.165 suggests profit-taking or resistance near $1.20–$1.30. A fall could hit support at $0.97–$1.05 soon (within 1–3 hours if historical patterns hold). 2. Opportunity for Upside: * The 40–60% chance of hitting $2 this week persists if Phase 2 results are positive. The pre-market bounce to $1.34 shows potential, but volume needs to sustain for a break above $1.73 resistance. * X sentiment is mixed—bullish on the rebound but cautious about a “dead cat” bounce if it can’t hold $1.30. 3. Dilution Concern: * The $100M shelf offering looms, but the warrant cancellation mitigates immediate dilution. No new issuance news today, so it’s not currently capping the rise, but any hint of fundraising could trigger a sell-off. Current Best Move: Hold for now but prepare to act. The $1.165 price is close to your CB recovery threshold, but the pre-market pullback from $1.34 suggests caution. Wait until 7:30 AM MDT (open) to see if it stabilizes or breaks $1.20. If it drops below $1.05, consider it a buy opportunity only if volume picks up and no dilution news emerges—otherwise, dilution could stall a rebound.

LaserGuy626

AI is good for questions like yours Medtronic is a global leader in medical technology, headquartered in Dublin, Ireland, with significant operations in the United States. Founded in 1949, it develops, manufactures, and sells medical devices and therapies to treat various conditions. The company operates in over 150 countries and focuses on improving patient outcomes through innovative healthcare solutions. Key Details About Medtronic: Industry: Medical Devices and Healthcare Technology Core Segments (based on fiscal 2024 data): Cardiovascular ($11.8 billion revenue): Includes pacemakers, defibrillators, heart valves (e.g., Evolut™ FX TAVR system), and ablation catheters for conditions like atrial fibrillation. Medical-Surgical ($8.4 billion revenue): Covers surgical innovations, including the Hugo robotic-assisted surgery system and stapling/endoscopy products. Neuroscience ($9.4 billion revenue): Encompasses neuromodulation devices (e.g., deep brain stimulation for Parkinson’s), spinal implants, and cranial solutions. Diabetes ($2.3 billion revenue, Q4 FY24 annualized): Features insulin pumps and continuous glucose monitors, though Medtronic plans to spin off this unit. Global Reach: Employs approximately 95,000 people and has a significant manufacturing and R&D presence in the US, Ireland, and other regions like Mexico and Switzerland. Innovation Focus: Invests heavily in R&D (e.g., AI-powered surgical systems, pulsed-field ablation) to address unmet medical needs, with a pipeline targeting conditions like heart failure and diabetes. Financial Profile: Publicly traded (NYSE: MDT), with a market cap of around $100 billion (as of recent estimates). Known for a strong dividend program, yielding ~3.19%, and nearing Dividend King status (50 years of consecutive dividend increases) in three years. Recent Developments: Medtronic is navigating potential US tariff risks (e.g., proposed 25% tariffs on imports) by evaluating its manufacturing footprint, particularly in Mexico. It’s also expanding robotic surgery and AI-driven diagnostics. Why It Matters: Medtronic’s products address critical healthcare needs, such as heart disease, neurological disorders, and chronic conditions, serving an aging global population. Its diversified portfolio and global scale make it a key player in the medical device industry, competing with companies like Intuitive Surgical, Abbott Laboratories, and Insulet. For more details, you can visit Medtronic’s investor relations page at https://investorrelations.medtronic.com or explore their product offerings at https://www.medtronic.com.

Temsamany

Resverlogix Corp. Annual Meeting of Shareholders Monday, June 30, 2025 at 1:00 PM MDT / 3:00 PM EDT. Log in and listen. You'll definitely find it here.

Shazam10-SAP

Missing out on ISRG and MDT wave is a more obvious miss than all the RKLB PLTR and ASTS FOMO’s combined- nobody knows if they’ll take off but healthcare stock? Obviously not going down with all the shit you all eat this weekend

Shazam10-SAP

Missing out on ISRG and MDT wave is a more obvious miss than all the RKLB PLTR and ASTS FOMO’s combined- nobody knows if they’ll take off but healthcare stock? Obviously not going down with all the shit you all wat

Dizzy-Intention3407

$Bone Biologics Corp which corp will acquire BBLG🦴👀🤗? Medtronic (NYSE: MDT), Johnson & Johnson (NYSE: JNJ), Stryker (NYSE: SYK), Zimmer Biomet (NYSE: ZBH), and Bioventus (NASDAQ: BVS).

Prior-Preparation896

Obvious answer that nobody has said are in the HC sector…SYK, WST, HCA, CRL, MDT, prob some large cap pharma as well

ValuableMiddle378

MDT gonna bull for the next year 😉

UniversityFun8209

Thoughts on medtronic MDT?

Revolutionary-Owl-79

8:40 MDT

AncientAckman

It's 4 AM in EDT, 3 AM in CDT, 2 AM in MDT, and 1 AM in PDT

AdamHorn8

https://preview.redd.it/otqpr3tu6jte1.jpeg?width=1290&format=pjpg&auto=webp&s=bfdd43e7ccd29976b626d2eea67cd6e2a4193096 I did sell just in time though. (Time in MDT)

Low-Librarian-6686

I'll see it earlier on MDT time. Bright and early

big-mo

MDT safe haven

Low-Librarian-6686

Glad I woke up at 5am MDT. Got in and out of TRNR, made a good profit and come back on the Reddit thread and sounds like a dumpster fire

5365616E48

MDT - Medtronic TSCO - Tractor Supply VICI - VICI Properties JNJ - Johnson & Johnson

Ok_One_8106

ANET VNET OKTA CELH and maybe MDT if it pulls back to 87 and PANW if it pulls back to 185. Hoping for a very strong March. TSLA also reaching a low enough point to consider buying

Ok_One_8106

somehow I am only down $2 today. NVO shares and MDT calls saved me. And a little bit from daytrading CELH calls. Realized P&L today of 10.8%, unrealized around the same. What everyone lost today I lost yesterday though buying the CVNA dip. Just picked up some CELH SOUN and IRBT after hours as buying the dip plays. Hope to snag 10% and get rid of all of them.

Ok_One_8106

ANET MDT - buy the dip! 18.00 TSLA strangle partially redeemed. Sold my call for 14. Now I need it to fall to save my 350 P

Intrepid-Peace-2350

So far MDT calls and Unity Calle

TimelyAd8822

Morgan Stanley on MDT $98 target, 5.59% upside

DyatAss

MDT has cheap calls for earnings play.

Low-Comfort5517

MDT calls

Bat-Sufficient

29:00 MDT

mrmrmrj

Indices might be down but lots of stocks up. I have a whole portfolio of them: BTI, HSY, MDT, LHX, COUR, DOW, BLND, IFF, DEO....the list goes on.

Inside-Unit-1564

MDT a green candle in a sea of red.

GoZukkYourself

Who profits the most from polio coming back? MDT?

hsuy10

MDT

marosa53

Super defensive: MO, PM, BTI, ENB, EPD, MDT. I love dividends.

GargantuasGoose

$WMT Q3’25 Revenue Estimate: 167.69 Bn Q3’25 Revenue Actual: 169.6 Bn ***BEAT*** Q3’25 EPS Estimate: 0.53 Q3’25 EPS Actual: 0.58 ***BEAT*** ——————————————————- $MDT Q3’25 Revenue Estimate: 8.27 Bn Q3’25 Revenue Actual: 8.40 Bn ***BEAT*** Q3’25 EPS Estimate: 1.25 Q3’25 EPS Actual: 1.26 ***BEAT*** + Raise in guidance

kid287ger

Medtronic $MDT

Boujee001029

!banbet $MDT $90 11/22

zmkarakas

my put for this week: SNOW, my call: MDT

bdh2067

I’d also add, holding both in my portfolio, that iSRG is up 170% over the past 5 years while MDT is actually down 17% So the market also sees them as pretty different companies

2014michave

|| || |Top 10 Stock Positions|Weight| |LQDA|11.74%| |MDT|9.28%| |PM|9.46%| |SYK|7.36%| |NMIH|5.46%| |VNOM|4.23%| |CCEC|4.81%| |X|4.47%| |Ebay|4.43%| |FRMO|4%|

paintedfaceless

MDT